ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Fortress Biotech Inc

Fortress Biotech Inc (FBIO)

1.82
0.04
(2.25%)
Closed 01 February 8:00AM
1.82
0.00
( 0.00% )
Pre Market: 8:02PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.82
Bid
1.70
Offer
1.90
Volume
63
0.00 Day's Range 0.00
1.355 52 Week Range 2.89
Market Cap
Previous Close
1.82
Open
-
Last Trade
1
@
1.82
Last Trade Time
20:01:19
Financial Volume
-
VWAP
-
Average Volume (3m)
578,089
Shares Outstanding
27,604,934
Dividend Yield
-
PE Ratio
-0.73
Earnings Per Share (EPS)
-2.49
Revenue
84.51M
Net Profit
-68.67M

About Fortress Biotech Inc

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the g... Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
-
Fortress Biotech Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FBIO. The last closing price for Fortress Biotech was US$1.82. Over the last year, Fortress Biotech shares have traded in a share price range of US$ 1.355 to US$ 2.89.

Fortress Biotech currently has 27,604,934 shares in issue. The market capitalisation of Fortress Biotech is US$50.24 million. Fortress Biotech has a price to earnings ratio (PE ratio) of -0.73.

FBIO Latest News

Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT

Study is the first randomized, controlled trial examining a vaccine’s effectiveness in controlling CMV in recipients of HSCT from vaccinated donors Encouraging pilot study results demonstrated...

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosiβ„’ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

SCOTTSDALE, Ariz., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (β€œJourney Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling...

Mustang Bio Announces Reverse Stock Split

WORCESTER, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (β€œMustang” or the β€œCompany”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s...

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease

Priority review granted for CUTX-101 with PDUFA target action date set for June 30, 2025 Cyprium is eligible to receive royalties and up to $129 million in aggregate development and sales...

Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes Disease

Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes Disease PR...

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adults Cosibelimab PDUFA goal date of December 28 for potential approval to treat metastatic or...

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

MIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (β€œAvenue” or the β€œCompany”), a specialty pharmaceutical company focused on the development and commercialization...

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

U.S. FDA approved Emrosiβ„’ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea in adults; launch expected in late Q1 or early Q2 of...

Mustang Bio Receives Positive Listing Determination from Nasdaq

WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (β€œMustang” or the β€œCompany”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s...

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma

MB-108 (HSV-1 oncolytic virus) is active and well tolerated in patients with recurrent glioblastoma in ongoing Phase 1 clinical trial Preclinical data support a novel combination of MB-108 (HSV-1...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.021.111111111111.81.881.71062186351.78569444CS
4-0.48-20.86956521742.32.361.71064199521.99227072CS
120.095.202312138731.732.361.415780891.98799529CS
260.021.111111111111.82.361.3555625661.8245294CS
52-0.01-0.5464480874321.832.891.3554055351.86809446CS
156-28.03-93.902847571229.8531.51.245045878.16307305CS
260-31.93-94.607407407433.7591.51.2466512132.86474919CS

FBIO - Frequently Asked Questions (FAQ)

What is the current Fortress Biotech share price?
The current share price of Fortress Biotech is US$ 1.82
How many Fortress Biotech shares are in issue?
Fortress Biotech has 27,604,934 shares in issue
What is the market cap of Fortress Biotech?
The market capitalisation of Fortress Biotech is USD 50.24M
What is the 1 year trading range for Fortress Biotech share price?
Fortress Biotech has traded in the range of US$ 1.355 to US$ 2.89 during the past year
What is the PE ratio of Fortress Biotech?
The price to earnings ratio of Fortress Biotech is -0.73
What is the cash to sales ratio of Fortress Biotech?
The cash to sales ratio of Fortress Biotech is 0.59
What is the reporting currency for Fortress Biotech?
Fortress Biotech reports financial results in USD
What is the latest annual turnover for Fortress Biotech?
The latest annual turnover of Fortress Biotech is USD 84.51M
What is the latest annual profit for Fortress Biotech?
The latest annual profit of Fortress Biotech is USD -68.67M
What is the registered address of Fortress Biotech?
The registered address for Fortress Biotech is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the Fortress Biotech website address?
The website address for Fortress Biotech is www.fortressbiotech.com
Which industry sector does Fortress Biotech operate in?
Fortress Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
UOKAMDJM Ltd
US$ 0.3824
(194.15%)
64.54M
REBNReborn Coffee Inc
US$ 5.48
(66.06%)
4.48M
MGYRMagyar Bancorp Inc
US$ 22.80
(59.00%)
8
NOEMCO2 Energy Transition Corporation
US$ 15.67
(58.44%)
7
DXRDaxor Corporation
US$ 11.90
(54.85%)
32
CYNCYNGN Inc
US$ 0.1405
(-47.96%)
3.73M
VIRXViracta Therapeutics Inc
US$ 0.08
(-47.19%)
250.81k
CEPOCantor Equity Partners I Inc
US$ 6.01
(-40.20%)
1
PITAHeramba Electric PLC
US$ 0.5487
(-39.03%)
49.11k
AIRJAirJoule Technologies Corporation
US$ 5.11
(-37.53%)
1
UOKAMDJM Ltd
US$ 0.3824
(194.15%)
64.54M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0501
(38.78%)
59.7M
RIMEAlgorhythm Holdings Inc
US$ 0.0301
(17.58%)
12.11M
TCTMTCTM Kids IT Education Inc
US$ 0.9525
(22.37%)
8.58M
PRPHProPhase Labs Inc
US$ 0.3134
(19.03%)
6.94M

FBIO Discussion

View Posts
rbl100 rbl100 1 month ago
You were right.

It was approved on 12/13/24.
πŸ‘οΈ0
rbl100 rbl100 1 month ago
Mr. Market (shorts) got their azz kicked LOL. Drug was approved by the FDA. Verify what I am saying. Go ahead. Here is the link to save you time:

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-cosibelimab-ipdl-metastatic-or-locally-advanced-cutaneous-squamous-cell-carcinoma

and this link in case you don't believe me:

https://www.aacr.org/patients-caregivers/progress-against-cancer/first-approval-for-a-new-immune-checkpoint-inhibitor/
πŸ‘οΈ0
rbl100 rbl100 1 month ago
It was approved.
πŸ‘οΈ0
rbl100 rbl100 1 month ago
Just found out FDA approved the cancer drug on the 13th. No one else knows. Just a tip for you. It was all done in secret I suppose.
πŸ‘οΈ0
rbl100 rbl100 1 month ago
FDA APPROVES FBIO cancer drug !!!!

FDA approves cosibelimab-ipdl for metastatic or locally advanced cutaneous squamous cell carcinoma

On December 13, 2024, the Food and Drug Administration approved cosibelimab-ipdl (Unloxcyt, Checkpoint Therapeutics, Inc.), a programmed death ligand-1 (PD-L1) blocking antibody, for adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation.

Full prescribing information for Unloxcyt will be posted on Drugs@FDA.
πŸ‘οΈ0
rbl100 rbl100 1 month ago
CKPT stake which is a partner of FBIO got approval and is a good thing. It took Apple 15 years to blow up in price. Holding what I have....
πŸ‘οΈ0
Paullee Paullee 2 months ago
Mr Market is not saying that
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
Confusing. Call the company
πŸ‘οΈ0
rbl100 rbl100 2 months ago
Did the FDA already tell FBIO that they rejected their filing? Someone on the CVM board says they did. That the FDA told the company executives that they are NOT getting approval. Is this true? How is this lawful? They were supposed to be getting the answer in a couple weeks.
πŸ‘οΈ0
chumfm chumfm 2 months ago
Always a good sign when you see insider buying.Threw DERM, FBIO has learned exactly what the FDA is looking for.This will be the time the stock gets the recognition it deserves.Good luck and good trading.
👍️ 1
StocktonCA StocktonCA 2 months ago
Institutions holding Fortress Biotech
Vanguard and Blackrock both own shares and many others

Β 

Get Institutions for :Β 



Fortress Biotech, Inc. (FBIO)Β Β  $0.29 0.00 (0.00%) as of 4:30 Mon 10/9

?
Download

Β Β Β Β Β  Institutional Holders
Viewing Quarter : Β Β  Total Institutions: ? 49Β Β Β ?Β 0

?

?

Total shares held :Β 

4,073,262 Β 

% of shares heldΒ :Β 

4.35% Β Changes In: ?

?

?

New/increased positions vsΒ Β Β 

old/decreased positions :Β 

?Β Β 10 Β 

Amount of shares held :Β 

724,444 Β 

% of shares held change :Β 

?Β Β 0.77% Β Quarter Price vs. Current Price: ?

?

?

Last Quarter's Starting Price :Β 

N/A Β 

Last Quarter's Ending Price :Β 

N/A Β 

Last Quarter's Average Price :Β 

N/A Β 

Change from last quarter's Β Β Β Β 

avg. price to the last closingΒ Β :Β 

(%) Β 

?

? Β  ?
All Securities Held :

Positions

Β Β Β Β  Shares

% Of
Total Shares

New Positions :

4

Β 146,601

Β 3.6%

Β  Increased Positions :

21

Β 993,803

Β 24.4%

Β  Unchanged Positions :

13

Β 460,712

Β 11.31%

Β  Decreased Positions :

11

-345,374

-8.48%

Β  Closed Positions :

4

-70,586

-1.73%

Β  Guru Positions :

0

Β 0%

Β  ?

Β  Page 1 of 1 Β 

Free Registration Required For Full Results





Β Β Β Β Β Β Β Β Β Β Β Β Institution NamePortfolio
PositionNew/Closed
Position
Filing Date
Total Shares
Total Value
Change in Shares
File?Β ?Β Β VANGUARD GROUP INC3804-2024-09-30625,054$903,00082,000

?

?Β ?Β Β CAMBRIDGE INVESTMENT RESEARCH ADVISORS INC2015-2024-09-30554,400$801,000465,500

?

?Β ?Β Β Rosalind Advisors Inc.23-2024-09-30502,828$727,000-104,969

?

?Β ?Β Β ACADIAN ASSET MANAGEMENT LLC1004-2024-09-30482,595$696,000205,087

?

?Β ?Β Β SHIKIAR ASSET MANAGEMENT INC53-2024-09-30235,969$342,00010,000

?

?Β ?Β Β ENVESTNET ASSET MANAGEMENT INC3830-2024-09-30183,946$266,00073,892

?

?Β ?Β Β PVG ASSET MANAGEMENT CORP24-2024-06-30155,675$266,00024,185

?

?Β ?Β Β GEODE CAPITAL MANAGEMENT LLC3834-2024-09-30168,607$244,00037,736

?

?Β ?Β Β NANTAHALA CAPITAL MANAGEMENT, LLC113-2024-09-30153,152$221,0000

?

?Β ?Β Β NATIONAL ASSET MANAGEMENT, INC.1222-2024-06-30120,814$207,000-23,886

?

?Β ?Β Β BLACKROCK INC.4260-2024-06-30109,957$188,00035,018

?

?Β ?Β Β BlackRock Inc.4257-2024-09-30111,028$160,0000

?

?Β ?Β Β CI Private Wealth LLC2238-2024-09-30100,326$145,0000

?

?Β ?Β Β GSA CAPITAL PARTNERS LLP1476-2024-09-3081,774$118,000-113,505

?

?Β ?Β Β RENAISSANCE TECHNOLOGIES LLC3233*New2024-09-3078,088$113,00078,088

?

?Β ?Β Β ATRIA INVESTMENTS LLC1865-2024-09-3071,484$103,00026,351

?

?Β ?Β Β 180 WEALTH ADVISORS LLC434-2024-09-3068,300$99,0005,950

?

?Β ?Β Β COMMONWEALTH EQUITY SERVICES LLC.3790-2024-09-3061,497$89,000-204

?

?Β ?Β Β HB Wealth Management LLC920*New2024-09-3055,333$80,00055,333

?

?Β ?Β Β Integrated Wealth Concepts LLC1610-2024-09-3046,100$67,00018,700

?

?Β ?Β Β NORTHERN TRUST CORP4163-2024-09-3041,373$60,000-4,785

?

?Β ?Β Β TITLEIST ASSET MANAGEMENT LLC272-2024-09-3039,000$56,000-1,080

?

?Β ?Β Β RSM US WEALTH MANAGEMENT LLC1550-2024-09-3036,250$52,0000

?

?Β ?Β Β CITADEL ADVISORS LLC4854-2024-09-3035,563$51,00026,268

?

?Β ?Β Β Telemetry Investments L.L.C.99*New2022-12-3172,000$47,00072,000

?

?Β ?Β Β PRUDENTIAL FINANCIAL INC2626-2024-09-3031,533$46,0009,800

?

?Β ?Β Β WEALTH ENHANCEMENT ADVISORY SERVICES LLC2546-2024-09-3030,550$44,000-20,266

?

?Β ?Β Β FMR LLC3699-2024-09-3026,467$38,0001,806

?

?Β ?Β Β STATE STREET CORP3937-2024-09-3025,966$38,0000

?

?Β ?Β Β GROUP ONE TRADING, L.P.1068-2024-09-3025,696$37,00014,800

?

?Β ?Β Β Financial Advocates Investment Management743-2024-09-3022,039$32,0000

?

?Β ?Β Β Meridian Wealth Management LLC621-2024-09-3020,500$30,000-45,000

?

?Β ?Β Β SUSQUEHANNA INTERNATIONAL GROUP, LLP5109-2024-09-3019,862$29,0001,011

?

?Β ?Β Β PFG Investments LLC988-2024-09-3019,291$28,0003,000

?

?Β ?Β Β Cetera Investment Advisers3555-2024-09-3018,989$27,0002,223

?

?Β ?Β Β MILLENNIUM MANAGEMENT LLC3828-2024-09-3017,151$25,000-48,025

?

?Β ?Β Β Weaver Consulting Group220-2024-09-3017,298$25,0005,895

?

?Β ?Β Β Gladstone Institutional Advisory LLC679-2024-09-3015,000$22,000-6,500

?

?Β ?Β Β CITIGROUP INC4204*New2024-09-3012,917$19,00012,917

?

?Β ?Β Β SeaCrest Wealth Management LLC644-2024-09-3012,000$17,0001,000

?

?Β ?Β Β WELLS FARGO & CO/MN5095-2024-09-308,654$13,000221

?

?Β ?Β Β MACQUARIE GROUP LTD1557-2024-09-306,666$10,0000

?

?Β ?Β Β TOWER RESEARCH CAPITAL LLC4378-2024-09-303,496$5,0002,536

?

?Β ?Β Β Russell Investments Group Ltd.3188-2024-09-302,080$3,0000

?

?Β ?Β Β MORGAN STANLEY6750-2024-09-302,024$3,0000

?

?Β ?Β Β J P MORGAN CHASE & CO5294-2024-09-30672$1,0000

?

?Β ?Β Β BANK OF AMERICA CORP /DE/6146-2024-09-30909$1,00027

?

?Β ?Β Β BNP PARIBAS ARBITRAGE SA3112-2024-09-30376$1,0000

?

?Β ?Β Β Qube Research & Technologies Ltd2738*Closed2024-09-300$0-2

?

?Β ?Β Β Axiom Investment Management LLC126*Closed2022-12-310$0-265

?

?Β ?Β Β FEDERATED INVESTORS INC /PA/2031*New2024-09-30263$0263

?

?Β ?Β Β NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO3351-2024-09-3033$0-40

?

?Β ?Β Β Advisor Group Holdings Inc.6930-2024-09-3030$0-1,000

?

?Β ?Β Β Cassaday & Co Wealth Management LLC320*Closed2024-09-300$0-20,584

?

?Β ?Β Β PROEQUITIES INC.6487-2024-09-300$00

?

?Β ?Β Β Keudell/Morrison Wealth Management230*Closed2024-09-300$0-13,000

?

?Β ?Β Β MYDA Advisors LLC141*Closed2024-09-300$0-37,000

?

?Β ?Β Β Newbridge Financial Services Group Inc.1123-2024-09-30133$00

?



Β  58 Records found

Β  1Β Β  Β 

Β  Page 1 of 1

?

?

?







Free Registration Required For Full Results

Β  Β Β Β Β 

Β Β Β Β Copyright © 2024 j3sg.com | Disclaimer & Terms of useΒ Β Β Β Β Β Β Β Β Β Products & Service Β About Us Β Contact Us

👍️ 1
rbl100 rbl100 2 months ago
Whatever you say.

Might even resume preferred dividends too. Ya never know.
πŸ‘οΈ0
Paullee Paullee 2 months ago
there is no insider buying going on
πŸ‘οΈ0
rbl100 rbl100 2 months ago
Insiders buying now too : )
πŸ‘οΈ0
chumfm chumfm 2 months ago
Yes the FDA date is Dec.28th,on or before.Both FBIO and CKPT could see a nice move into the new year.Good luck and good trading.
πŸ‘οΈ0
rbl100 rbl100 2 months ago
FDA approval is expected by end of month
πŸ‘οΈ0
StocktonCA StocktonCA 2 months ago
Houston, We have Lift-off!!!!
πŸ‘οΈ0
StocktonCA StocktonCA 2 months ago
Undervalued, ready to break out!
πŸ‘οΈ0
chumfm chumfm 3 months ago
Will break it's 52 week high of $4.43 when the FDA gives it the nod on Monday Nov.4th,2024.They will be the only bio to provide such.It will increase by the end of today and expode on Monday,with the approval.Good luck and good trading.
πŸ‘οΈ0
rbl100 rbl100 4 months ago
They are probably a shorter. The lowest form of humanity. These people bankrupt companies and kill jobs for others who work in these companies that get their stocks shorted. They thrive on wickedness and evil. And get joy and jollies from hurting others.
πŸ‘οΈ0
investtemp investtemp 5 months ago
If your book only contained all your post on I hub it would be about 500 pages
πŸ‘οΈ0
Monksdream Monksdream 5 months ago
FBIO 10 day hourly
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
FBIO 10Q due AUGUST 19
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
FBIO under $3
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
FBIO under $2
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
FBIO under $2
πŸ‘οΈ0
Monksdream Monksdream 11 months ago
FBIO under $2
πŸ‘οΈ0
triannual triannual 1 year ago
Buy order @ $1.40 / 1000 shares. GLTA!
πŸ‘οΈ0
rbl100 rbl100 1 year ago
Not exactly certain, but I am holding for the results. I almost sold some shares for some pocket money but held off. Don't want to miss any news. My luck is I sell and then news hits and it takes off. My CA is $1.29 per share. No skin off my back with the drop.
πŸ‘οΈ0
conix conix 1 year ago
At some point, these biotechs need to prove they have promising drug candidates in clinical trials and are not just good at raising capital
👍️ 1
Sierra20 Sierra20 1 year ago
$11 million offering. Ouch.
πŸ‘οΈ0
Sierra20 Sierra20 1 year ago
1/3 PDUFA is no longer valid.
πŸ‘οΈ0
rabbit67 rabbit67 1 year ago
When is next fda news jan19?
πŸ‘οΈ0
1hot toddy 1hot toddy 1 year ago
yahoo finance says $41 price in 1 year $$$$$$$$$$$
πŸ‘οΈ0
rbl100 rbl100 1 year ago
This thing could be like Bill Bixby. You know the 1978 series whereby just before he gets extreme stress and anger. Holding for next year+++.
πŸ‘οΈ0
rbl100 rbl100 1 year ago
Check it out now. Glad I held. Very low float. Nice gem I was tipped off about and looking forward to the FDA approvals.
πŸ‘οΈ0
1hot toddy 1hot toddy 1 year ago
MONSTER BIG BUYS 15000 AND 14000 SHARES. $30K EACH BUY
πŸ‘οΈ0
rbl100 rbl100 1 year ago
Shorts kept it in check. Profit takers made it drop. No volume for them to brag about. So the drop is normal business as usual. If you see a large drop AND very large abnormal volume... that is when to worry. Remember insiders bought this stock at an average of $9.00 + per share pre R/S. They know it is going into the $40's next year... Nice 20 bagger.
👍️ 1
TrendTrade2016 TrendTrade2016 1 year ago
FBIO PUSHING UP IN PRE, LETS SEE THAT 3 DOLLA
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 1 year ago
Stick to your hobby of posting 52 week high and 52 week lows chief.
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 1 year ago
FBIO HOLY FUC!!!
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 1 year ago
FBIO FAB!!!
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 1 year ago
FBIO MONSTER
πŸ‘οΈ0
rbl100 rbl100 1 year ago
More than the float traded today. Unless I am seeing things LOL.
👍️ 1
TrendTrade2016 TrendTrade2016 1 year ago
Chief keep posting your 52 week highs and lows. Get a better hobby
πŸ‘οΈ0
rbl100 rbl100 1 year ago
Then don't waste your time here. No one needs anyone to protect them from themselves. We have enough with gubberment. Speaking of which should be abolished.
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
It’s a wash trade event
You’re pushing the envelope
πŸ‘οΈ0
rbl100 rbl100 1 year ago
That is fine, but this one is looking promising as time goes on. Got to be in it to win it. FDA rubber stamps approvals these days. Years ago it was a different story. They relaxed most standards, so not worried at all. late 2020 and 2021 proved it with the CLOVER schots. FDA is nothing but a paid co-conspirator to bad. So use it to your benefit.
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 1 year ago
FBIO...NEXT STOP 2.27
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 1 year ago
FBIO...MONSTER
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock